ArticleInvestigational new drugs2022

A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target.

Ji-Li Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.